Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr Yvonne Bury.
Newcastle Authors
Title
Year
Full text
Bassier Zadran
Daniel Wainwright
Dr Yvonne Bury
Dr Saimir Luli
Rachel Howarth
et al.
Impact of retrotransposon protein L1 ORF1p expression on oncogenic pathways in hepatocellular carcinoma: the role of cytoplasmic PIN1 upregulation
2023
Dr Daniel Geh
Robyn Watson
Gourab Sen
Jeremy French
John Hammond
et al.
COVID-19 and liver cancer: Lost patients and larger tumours
2022
Nicola Dyson
Dr Nicole Kattner
Minna Honkanen-Scott
Bethany Hunter
Jennifer Doyle
et al.
Development and Application of a Semi quantitative Scoring Method for Ultrastructural Assessment of Acute Stress in Pancreatic Islets
2022
Dr Sam Tingle
Dr Emily Thompson
Lucy Bates
Dr Ibrahim Ibrahim
Dr Olivier Govaere
et al.
Pharmacological testing of therapeutics using normothermic machine perfusion: A pilot study of 2,4-dinitrophenol delivery to steatotic human livers
2022
Dr Praveen Dhondurao Sudhindar
Daniel Wainwright
Dr Santu Saha
Rachel Howarth
Misti McCain
et al.
HCV Activates Somatic L1 Retrotransposition—A Potential Hepatocarcinogenesis Pathway
2021
Dr Sam Tingle
Dr Ibrahim Ibrahim
Dr Emily Thompson
Lucy Bates
Dr Ashwin Sivaharan
et al.
Methaemoglobinaemia Can Complicate Normothermic Machine Perfusion of Human Livers
2021
Dr Sam Tingle
Dr Emily Thompson
Lucy Bates
Dr Ibrahim Ibrahim
Rodrigo Figueiredo
et al.
Microvascular obstructions in portal bile duct capillaries and hepatic sinusoids during normothermic machine perfusion of marginal human livers
2021
Dr Nicole Kattner
Nicola Dyson
Dr Yvonne Bury
Dr Dina Tiniakos
Tracey Davey
et al.
Development and validation of a quantitative electron microscopy score to assess acute cellular stress in the human exocrine pancreas
2020
Dr Ruchi Shukla
Professor Helen Reeves
Professor Stuart McPherson
Misti McCain
Dr Praveen Dhondurao Sudhindar
et al.
Hepatitis C virus infection, endogenous retrotransposons activation and cancer risk
2020
Dr Beate Haugk
Dr Yvonne Bury
Pancreatic pathology: where are we in 2019?
2019
Professor Stuart McPherson
Dr Nina Wilson
Dr Dina Tiniakos
Dr Jennifer Wilkinson
Professor Alastair Burt
et al.
A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis
2017
Dr Beate Haugk
Dr Yvonne Bury
Dr Louise Coats
Dr John O'Sullivan
Dr Mark Hudson
et al.
Defining the role of liver biopsy in the assessment of liver fibrosis in patients with Fontan circulation
2017
Professor Colin Rees
Dr Yvonne Bury
Are there biological differences between screen-detected and interval colorectal cancers in the English Bowel Cancer Screening Programme?
2016
Dr Dina Tiniakos
Professor Quentin Anstee
Professor Chris Day
Professor Alastair Burt
Dr John Brain
et al.
Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference
2016
Dr Dina Tiniakos
Dr Yvonne Bury
p62 (SQSTM1) expression in human liver disease: Preliminary results
2015
Dr Dina Tiniakos
Dr John Brain
Dr Yvonne Bury
Role of Histopathology in Autoimmune Hepatitis
2015
Dr Yvonne Bury
Naomi Brown
Dr Dina Tiniakos
p53 expression in human hepatocellular carcinoma (HCC): correlation with dysadherin expression and patient prognosis
2014
David Bradburn
Dr Yvonne Bury
Professor Colin Rees
Screen-detected colorectal cancers are associated with an improved outcome compared with stage-matched interval cancers
2014
Dr Yvonne Bury
The enhanced role of biomedical scientists in the histological dissection of axillary lymph node clearance specimens
2014
Professor Pierre Bedossa
Professor Alastair Burt
Dr Dina Tiniakos
Dr John Brain
Dr Yvonne Bury
et al.
Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease
2014
Dr Dina Tiniakos
Dr John Brain
Dr Yvonne Bury
Utility and appropriateness of the FLIP algorithm and SAF score in the evaluation of biopsies of nonalcoholic fatty liver disease.
2014
Dr Nigel Kirkham
Dr Yvonne Bury
Dr Neelima Thampy
A Structured Approach to the Diagnosis of Borderline Melanocytic Skin Lesions
2013
Dr James Orr
Dr Yvonne Bury
Dr Mark Hudson
Dr Steven Masson
Liver transplantation for acute liver failure caused by macrophage activation syndrome
2013
Dr Michael Bramble
Dr Yvonne Bury
Professor Colin Rees
Screen-detected colorectal cancers are associated with an improved outcome when compared with interval cancers when matched for stage
2013